Charles Andrew Stewart
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$5.8MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $5.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 20, 2025 | NIH | SBIR Phase II Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD) | $1.5M | CARTESIAN THERAPEUTICS INC |
| Jun 20, 2022 | NIH | SBIR Phase II Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distress Syndrome | $999K | CARTESIAN THERAPEUTICS INC |
| Apr 29, 2021 | NIH | SBIR Phase II Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distress Syndrome | $999K | CARTESIAN THERAPEUTICS INC |
| Apr 3, 2021 | NIH | SBIR Phase II Phase 1/2 Clinical Study of Humanized Anti-BCMA CAR T Cells in Relapsed/Refractory Multiple Myeloma (MM) | $988K | CARTESIAN THERAPEUTICS INC |
| Apr 21, 2020 | NIH | SBIR Phase II Phase 1/2 Clinical Study of Humanized Anti-BCMA CAR T Cells in Relapsed/Refractory Multiple Myeloma (MM) | $988K | CARTESIAN THERAPEUTICS INC |
| Aug 1, 2018 | NIH | SBIR Phase I Transient anti-BCMA CAR T-cells for Treatment of Multiple Myeloma | $299K | CARTESIAN THERAPEUTICS INC |
Peer ranks
Federal funding#206
Awards as PI#315
Patents#273
Companies
- CARTESIAN THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.